Global Ophthalmic Drugs Market Research Report 2016

November 2016 | 114 pages | ID: GC28432BBB3EN
QYResearch

Abstracts

Notes:

Production, means the output of Ophthalmic Drugs

Revenue, means the sales value of Ophthalmic Drugs

This report studies Ophthalmic Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Novartis
• Santen Pharmaceutical
• Merck
• Roche Holding AG
• Pfizer
• Allergan
• Valeant
• Regeneron
• Bayer
• Senju
• Akorn

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Ophthalmic Drugs in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Prescription Drugs
• OTC Drugs
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Ophthalmic Drugs in each application, can be divided into

• Dry Eye Drugs
• Retinal Drugs
• Anti-inflammatory/allergy/infective Drugs
• Anti-glaucoma Drugs
• Others

Contents

Global Ophthalmic Drugs Market Research Report 2016

1 OPHTHALMIC DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Ophthalmic Drugs
1.2 Ophthalmic Drugs Segment by Type
  1.2.1 Global Production Market Share of Ophthalmic Drugs by Type in 2015
  1.2.2 Prescription Drugs
  1.2.3 OTC Drugs
  1.2.4 Type III
1.3 Ophthalmic Drugs Segment by Application
  1.3.1 Ophthalmic Drugs Consumption Market Share by Application in 2015
  1.3.2 Dry Eye Drugs
  1.3.3 Retinal Drugs
  1.3.4 Anti-inflammatory/allergy/infective Drugs
  1.3.5 Anti-glaucoma Drugs
  1.3.6 Others
1.4 Ophthalmic Drugs Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Ophthalmic Drugs (2011-2021)

2 GLOBAL OPHTHALMIC DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Ophthalmic Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Ophthalmic Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Ophthalmic Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Ophthalmic Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Ophthalmic Drugs Market Competitive Situation and Trends
  2.5.1 Ophthalmic Drugs Market Concentration Rate
  2.5.2 Ophthalmic Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL OPHTHALMIC DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Ophthalmic Drugs Production by Region (2011-2016)
3.2 Global Ophthalmic Drugs Production Market Share by Region (2011-2016)
3.3 Global Ophthalmic Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL OPHTHALMIC DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Ophthalmic Drugs Consumption by Regions (2011-2016)
4.2 North America Ophthalmic Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Ophthalmic Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Ophthalmic Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Ophthalmic Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Ophthalmic Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Ophthalmic Drugs Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL OPHTHALMIC DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Ophthalmic Drugs Production and Market Share by Type (2011-2016)
5.2 Global Ophthalmic Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Ophthalmic Drugs Price by Type (2011-2016)
5.4 Global Ophthalmic Drugs Production Growth by Type (2011-2016)

6 GLOBAL OPHTHALMIC DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Ophthalmic Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Ophthalmic Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL OPHTHALMIC DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Novartis
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Ophthalmic Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Novartis Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Santen Pharmaceutical
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Ophthalmic Drugs Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Santen Pharmaceutical Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Merck
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Ophthalmic Drugs Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Merck Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Roche Holding AG
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Ophthalmic Drugs Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Roche Holding AG Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Pfizer
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Ophthalmic Drugs Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Pfizer Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Allergan
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Ophthalmic Drugs Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Allergan Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Valeant
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Ophthalmic Drugs Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Valeant Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Regeneron
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Ophthalmic Drugs Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Regeneron Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Bayer
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Ophthalmic Drugs Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Bayer Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Senju
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Ophthalmic Drugs Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Senju Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Akorn

8 OPHTHALMIC DRUGS MANUFACTURING COST ANALYSIS

8.1 Ophthalmic Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Ophthalmic Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Ophthalmic Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Ophthalmic Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL OPHTHALMIC DRUGS MARKET FORECAST (2016-2021)

12.1 Global Ophthalmic Drugs Production, Revenue Forecast (2016-2021)
12.2 Global Ophthalmic Drugs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Ophthalmic Drugs Production Forecast by Type (2016-2021)
12.4 Global Ophthalmic Drugs Consumption Forecast by Application (2016-2021)
12.5 Ophthalmic Drugs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ophthalmic Drugs
Figure Global Production Market Share of Ophthalmic Drugs by Type in 2015
Figure Product Picture of Prescription Drugs
Table Major Manufacturers of Prescription Drugs
Figure Product Picture of OTC Drugs
Table Major Manufacturers of OTC Drugs
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Ophthalmic Drugs Consumption Market Share by Application in 2015
Figure Dry Eye Drugs Examples
Figure Retinal Drugs Examples
Figure Anti-inflammatory/allergy/infective Drugs Examples
Figure Anti-glaucoma Drugs Examples
Figure Others Examples
Figure North America Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Ophthalmic Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Ophthalmic Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Ophthalmic Drugs Capacity of Key Manufacturers (2015 and 2016)
Table Global Ophthalmic Drugs Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Ophthalmic Drugs Capacity of Key Manufacturers in 2015
Figure Global Ophthalmic Drugs Capacity of Key Manufacturers in 2016
Table Global Ophthalmic Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Ophthalmic Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Ophthalmic Drugs Production Share by Manufacturers
Figure 2016 Ophthalmic Drugs Production Share by Manufacturers
Table Global Ophthalmic Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Ophthalmic Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Ophthalmic Drugs Revenue Share by Manufacturers
Table 2016 Global Ophthalmic Drugs Revenue Share by Manufacturers
Table Global Market Ophthalmic Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Ophthalmic Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Ophthalmic Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Ophthalmic Drugs Product Type
Figure Ophthalmic Drugs Market Share of Top 3 Manufacturers
Figure Ophthalmic Drugs Market Share of Top 5 Manufacturers
Table Global Ophthalmic Drugs Capacity by Regions (2011-2016)
Figure Global Ophthalmic Drugs Capacity Market Share by Regions (2011-2016)
Figure Global Ophthalmic Drugs Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Ophthalmic Drugs Capacity Market Share by Regions
Table Global Ophthalmic Drugs Production by Regions (2011-2016)
Figure Global Ophthalmic Drugs Production and Market Share by Regions (2011-2016)
Figure Global Ophthalmic Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Ophthalmic Drugs Production Market Share by Regions
Table Global Ophthalmic Drugs Revenue by Regions (2011-2016)
Table Global Ophthalmic Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Ophthalmic Drugs Revenue Market Share by Regions
Table Global Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table China Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table India Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Ophthalmic Drugs Consumption Market by Regions (2011-2016)
Table Global Ophthalmic Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Ophthalmic Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Ophthalmic Drugs Consumption Market Share by Regions
Table North America Ophthalmic Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Ophthalmic Drugs Production, Consumption, Import & Export (2011-2016)
Table China Ophthalmic Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Ophthalmic Drugs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Ophthalmic Drugs Production, Consumption, Import & Export (2011-2016)
Table India Ophthalmic Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Ophthalmic Drugs Production by Type (2011-2016)
Table Global Ophthalmic Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Ophthalmic Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Ophthalmic Drugs by Type
Table Global Ophthalmic Drugs Revenue by Type (2011-2016)
Table Global Ophthalmic Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Ophthalmic Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Ophthalmic Drugs by Type
Table Global Ophthalmic Drugs Price by Type (2011-2016)
Figure Global Ophthalmic Drugs Production Growth by Type (2011-2016)
Table Global Ophthalmic Drugs Consumption by Application (2011-2016)
Table Global Ophthalmic Drugs Consumption Market Share by Application (2011-2016)
Figure Global Ophthalmic Drugs Consumption Market Share by Application in 2015
Table Global Ophthalmic Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Ophthalmic Drugs Consumption Growth Rate by Application (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Ophthalmic Drugs Market Share (2011-2016)
Table Santen Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Santen Pharmaceutical Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Santen Pharmaceutical Ophthalmic Drugs Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Ophthalmic Drugs Market Share (2011-2016)
Table Roche Holding AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Holding AG Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Holding AG Ophthalmic Drugs Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Ophthalmic Drugs Market Share (2011-2016)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Ophthalmic Drugs Market Share (2011-2016)
Table Valeant Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Valeant Ophthalmic Drugs Market Share (2011-2016)
Table Regeneron Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Regeneron Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Regeneron Ophthalmic Drugs Market Share (2011-2016)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Ophthalmic Drugs Market Share (2011-2016)
Table Senju Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Senju Ophthalmic Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Senju Ophthalmic Drugs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ophthalmic Drugs
Figure Manufacturing Process Analysis of Ophthalmic Drugs
Figure Ophthalmic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ophthalmic Drugs Major Manufacturers in 2015
Table Major Buyers of Ophthalmic Drugs
Table Distributors/Traders List
Figure Global Ophthalmic Drugs Production and Growth Rate Forecast (2016-2021)
Figure Global Ophthalmic Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Ophthalmic Drugs Production Forecast by Regions (2016-2021)
Table Global Ophthalmic Drugs Consumption Forecast by Regions (2016-2021)
Table Global Ophthalmic Drugs Production Forecast by Type (2016-2021)
Table Global Ophthalmic Drugs Consumption Forecast by Application (2016-2021)